Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1959 Oct;38(10 Pt 1-2):1672–1682. doi: 10.1172/JCI103945

OBSERVATIONS ON CERULOPLASMIN IN WILSON'S DISEASE*,

Andrew Sass-Kortsak 1, Morris Cherniak 1,, Douglas W Geiger 1,§, Robert J Slater 1,ǁ
PMCID: PMC444134  PMID: 14441876

Full text

PDF
1674

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEARN A. G. Genetic and biochemical aspects of Wilson's disease. Am J Med. 1953 Oct;15(4):442–449. doi: 10.1016/0002-9343(53)90134-x. [DOI] [PubMed] [Google Scholar]
  2. BEARN A. G. Genetic and biochemical aspects of Wilson's disease. Am J Med. 1953 Oct;15(4):442–449. doi: 10.1016/0002-9343(53)90134-x. [DOI] [PubMed] [Google Scholar]
  3. BEARN A. G., KUNKEL H. G. Metabolic studies in Wilson's disease using Cu64. J Lab Clin Med. 1955 Apr;45(4):623–631. [PubMed] [Google Scholar]
  4. BEARN A. G. Wilson's disease; an inborn error of metabolism with multiple manifestations. Am J Med. 1957 May;22(5):747–757. doi: 10.1016/0002-9343(57)90125-0. [DOI] [PubMed] [Google Scholar]
  5. BICKEL H., GOLLNER I., GRUTER W., SCHULTZE H. E. Versuche zur Coeruloplasminsubstitution bei der hepatocerebralen Degeneration (Wilsonsche Krankheit). Klin Wochenschr. 1956 Sep 15;34(35-36):961–968. doi: 10.1007/BF01473248. [DOI] [PubMed] [Google Scholar]
  6. BUSH J. A., MAHONEY J. P., MARKOWITZ H., GUBLER C. J., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism. XIV. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration. J Clin Invest. 1955 Dec;34(12):1766–1778. doi: 10.1172/JCI103232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. BUTTERWORTH C. E., Jr, GUBLER C. J., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism. XXVI. Plasma copper in patients with tropical sprue. Proc Soc Exp Biol Med. 1958 Jul;98(3):594–597. doi: 10.3181/00379727-98-24117. [DOI] [PubMed] [Google Scholar]
  8. CARTWRIGHT G. E., HODGES R. E., GUBLER C. J., MAHONEY J. P., DAUM K., WINTROBE M. M., BEAN W. B. Studies on copper metabolism. XIII. Hepatolenticular degeneration. J Clin Invest. 1954 Nov;33(11):1487–1501. doi: 10.1172/JCI103027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. COPELAND B. E. Standard deviation; a practical means for the measurement and control of the precision of clinical laboratory determinations. Am J Clin Pathol. 1957 May;27(5):551–558. doi: 10.1093/ajcp/27.5.551. [DOI] [PubMed] [Google Scholar]
  10. Eden A., Green H. H. Micro-determination of copper in biological material. Biochem J. 1940 Sep;34(8-9):1202–1208. doi: 10.1042/bj0341202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. GUBLER C. J., BROWN H., MARKOWITZ H., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism. XXIII. Portal (Laennec's) cirrhosis of the liver. J Clin Invest. 1957 Aug;36(8):1208–1216. doi: 10.1172/JCI103517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. IBER F. L., CHALMERS T. C., UZMAN L. L. Studies of protein metabolism in hepatolenticular degeneration. Metabolism. 1957 Jul;6(4):388–396. [PubMed] [Google Scholar]
  13. JENSEN W. N., KAMIN H. Copper transport and excretion in normal subjects and in patients with Laennec's cirrhosis and Wilson's disease: a study with CU64. J Lab Clin Med. 1957 Feb;49(2):200–210. [PubMed] [Google Scholar]
  14. KUNKEL H. G., TISELIUS A. Electrophoresis of proteins on filter paper. J Gen Physiol. 1951 Sep;35(1):89–118. doi: 10.1085/jgp.35.1.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. MARKOWITZ H., GUBLER C. J., MAHONEY J. P., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome. J Clin Invest. 1955 Oct;34(10):1498–1508. doi: 10.1172/JCI103201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. RAVIN H. A. Rapid test for hepatolenticular degeneration. Lancet. 1956 May 19;270(6925):726–727. doi: 10.1016/s0140-6736(56)90751-6. [DOI] [PubMed] [Google Scholar]
  17. SCHEINBERG I. H., GITLIN D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science. 1952 Oct 31;116(3018):484–485. doi: 10.1126/science.116.3018.484. [DOI] [PubMed] [Google Scholar]
  18. SCHEINBERG I. H., MORELL A. G. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease. J Clin Invest. 1957 Aug;36(8):1193–1201. doi: 10.1172/JCI103515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. WALSHE J. M. Hepatolenticular degeneration (Wilson's disease). Br Med Bull. 1957 May;13(2):132–135. doi: 10.1093/oxfordjournals.bmb.a069590. [DOI] [PubMed] [Google Scholar]
  20. ZIPURSKY A., DEMPSEY H., MARKOWITZ H., CARTWRIGHT G., WINTROBE M. M. Studies on copper metabolism. XXIV. Hypocupremia in infancy. AMA J Dis Child. 1958 Aug;96(2):148–158. doi: 10.1001/archpedi.1958.02060060150004. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES